Life Science Pharmaceuticals, Ludwig Institute for Cancer Research deal

The institute granted Life Science exclusive worldwide rights to develop and commercialize three MAbs for cancer and autoimmune diseases. The antibodies target epidermal growth factor receptor (EGFR)...